Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Johnson Johnson

J&J Files For Authorization Of COVID-19 Vaccine Booster

The filing comes after the FDA last week scheduled an Oct. 15 meeting of its expert advisory committee to discuss whether to authorize a second shot of J&J's single-dose vaccine.

Read More

Johnson & Johnson Files Application To Conduct Study On Its COVID Vaccine In Adolescents

Union Health Minister Mansukh Mandaviya had said the approval would further boost the country's collective fight against the novel coronavirus infection.

Read More

Johnson & Johnson Exploring Ways To Accelerate Delivery Of Its COVID Vaccine In India

The company also said as per a recent announcement by the Indian drug regulator, there is no longer a need to conduct bridging clinical trials of COVID-19 vaccines in India.

Read More

Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU

The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.

Read More

India Seeks Funds From Quad Alliance To Match China's Vaccine Push: Source

Indian companies such as the Serum Institute of India (SII), Bharat Biotech, Biological E and Cadila Healthcare have the combined capacity to produce billions of doses of their own vaccines or contract-manufacture for others.

Read More

Wall Street Rallies On US Stimulus And Vaccine Hopes As Bond Markets Calm

Emerging market stocks rose 1.71%. MSCI's broadest index of Asia-Pacific shares outside Japan closed 1.83% higher, while Japan's Nikkei rose 2.41%.

Read More

J&J Waiting On New Plant Approval To Ship High Volumes Of Vaccine: Executive

J&J is also working to expand its manufacturing capacity globally and is in talks with potential new partners, Stoffels said, adding that he expects to be able to announce more manufacturing deals soon.

Read More

FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs Up Expected

J&J's vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.

Read More

France's Sanofi To Help Johnson & Johnson Manufacture COVID-19 Vaccine

Sanofi will provide Johnson & Johnson access to the established infrastructure and expertise of its vaccine manufacturing plant in Marcy l'Etoile, France, to formulate and fill vials of Johnson & Johnson's Janssen COVID-19 vaccine candidate in 2021 at a rate of approximately 12 million doses per month.

Read More

Wall Street Closes Higher On Vaccine Lift; S&P 500, Nasdaq At Records

Johnson & Johnson rose 1.73% to help lift both the Dow and S&P 500 after the company said it could obtain late-stage trial results of a single-dose COVID-19 vaccine it is developing in January, earlier than expected.

Read More

J&J Starts Two-Dose Trial Of Its COVID-19 Candidate Vaccine In The UK

J&J signed an agreement for the two-dose global Phase III clinical trial with the British government in August, to run in parallel with a 60,000-person trial of a single shot of the experimental vaccine which was launched in September.

Read More

Medicago's COVID-19 Vaccine Triggers Immune Response In Early-Stage Trial

Medicago is Canada's most advanced domestic COVID-19 vaccine project, but lags larger, global rivals such as Pfizer, AstraZeneca Plc and Johnson & Johnson which have begun late-stage trials.

Read More

Johnson & Johnson Fails To Overturn $2.12 Billion Baby Powder Verdict, Plans Supreme Court Appeal

The Missouri Supreme Court let stand a June 23 decision by a state appeals court, which upheld a jury's July 2018 finding of liability but reduced J&J's payout from $4.69 billion after dismissing claims by some of the 22 plaintiffs.

Read More

J&J Plans To Test Its COVID-19 Vaccine In Ages 12-18 Soon

J&J started testing the vaccine in adults in a 60,000-volunteer Phase III study in late September. It had to pause the trial earlier this month because of a serious medical event in one participant. The study resumed last week.

Read More

J&J To Contribute Up To $5 Billion To Potential US Opioid Settlement

That proposal also called for the drug distributors McKesson Corp, Cardinal Health and AmerisourceBergen to pay a combined $18 billion, but the framework met resistance from some states and local governments.

Read More